{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Psoriatic+Conditions", "query": { "condition": "Psoriatic Conditions" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 28, "total_pages": 3, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Psoriatic+Conditions&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-06-10T22:14:48.073Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06864026", "title": "A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Psoriatic Arthritis", "Overweight or Obesity" ], "interventions": [ { "name": "Tirzepatide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 200, "start_date": "2025-03-06", "completion_date": "2027-11", "has_results": false, "last_update_posted_date": "2026-02-10", "last_synced_at": "2026-06-10T22:14:48.073Z", "location_count": 53, "location_summary": "Avondale, Arizona • Chandler, Arizona • Flagstaff, Arizona + 48 more", "locations": [ { "city": "Avondale", "state": "Arizona" }, { "city": "Chandler", "state": "Arizona" }, { "city": "Flagstaff", "state": "Arizona" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "Glendale", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT06864026" }, { "nct_id": "NCT04806620", "title": "Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Post-Acute COVID-19 Syndrome", "ME/CFS", "Rheumatic Arthritis", "Juvenile Rheumatoid Arthritis (JRA)", "Psoriatic Arthritis (PsA)", "Ankylosing Spondylitis (AS)", "Autoimmune Encephalitis", "Celiac Disease", "Celiac Disease in Children", "Chronic Lyme Disease", "Post-treatment Lyme Disease Syndrome", "Crohn's Disease", "Dysautonomia", "Anorexia Nervosa", "Bulimia Nervosa", "ARFID", "Avoidant / Restrictive Food Intake Disorder", "Ehlers Danlos Syndrome", "Endometriosis", "Fibromyalgia (FM)", "Long COVID", "Lupus", "Migraines", "Mast Cell Activation Syndrome", "Multiple Sclerosis", "Myalgic Encephalomyelitis (ME)", "Myasthenia Gravis, Generalized", "Myasthenia Gravis in Children", "Narcolepsy", "Obsessive Compulsive Disorder (OCD)", "PANDAS", "Pediatric Acute-onset Neuropsychiatric Syndrome (PANS)", "POTS - Postural Orthostatic Tachycardia Syndrome", "General Anxiety Disorder, Social Anxiety Disorder", "PTSD - Post Traumatic Stress Disorder", "Psoriasis", "Traumatic Brain Injury", "Tourette's Syndrome", "Inflammatory Bowel Disease (IBD)", "Autoimmune Diseases", "Neurological Diseases or Conditions", "Psychiatric Disorder", "Sjogren's Syndrome", "Ulcerative Colitis and Crohn's Disease" ], "interventions": [], "intervention_types": [], "sponsor": "Brain Inflammation Collaborative", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "2 Years", "maximum_age": null, "sex": "ALL", "summary": "2 Years and older" }, "enrollment_count": 10000, "start_date": "2023-07-05", "completion_date": "2030-12-31", "has_results": false, "last_update_posted_date": "2026-01-22", "last_synced_at": "2026-06-10T22:14:48.073Z", "location_count": 1, "location_summary": "Delafield, Wisconsin", "locations": [ { "city": "Delafield", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT04806620" }, { "nct_id": "NCT04504136", "title": "Regulation of Mucosal Healing in Inflammatory Bowel Disease", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Inflammatory Bowel Diseases" ], "interventions": [ { "name": "Serial Biopsy", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Terrence A Barrett", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 60, "start_date": "2021-04-30", "completion_date": "2026-06-01", "has_results": false, "last_update_posted_date": "2025-06-08", "last_synced_at": "2026-06-10T22:14:48.073Z", "location_count": 1, "location_summary": "Lexington, Kentucky", "locations": [ { "city": "Lexington", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT04504136" }, { "nct_id": "NCT01172938", "title": "Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Psoriatic Arthritis" ], "interventions": [ { "name": "Apremilast 20mg", "type": "DRUG" }, { "name": "Apremilast 30mg", "type": "DRUG" }, { "name": "Placebo + 20 mg Apremilast", "type": "DRUG" }, { "name": "Placebo + 30 mg Apremilast", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amgen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 504, "start_date": "2010-06-02", "completion_date": "2016-10-27", "has_results": true, "last_update_posted_date": "2020-06-19", "last_synced_at": "2026-06-10T22:14:48.073Z", "location_count": 27, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • La Jolla, California + 24 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "La Jolla", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "Upland", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01172938" }, { "nct_id": "NCT04402086", "title": "Rheumatology Patient Registry and Biorepository", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Rheumatic Diseases", "Adult Onset Still Disease", "Ankylosing Spondylitis", "Psoriatic Arthritis", "Reactive Arthritis", "Antiphospholipid Syndrome", "Systemic Lupus Erythematosus", "Behcet Disease", "Dermatomyositis", "Polymyositis", "Giant Cell Arteritis", "Lyme Disease", "Mixed Connective Tissue Disease", "Polymyalgia Rheumatica", "Rheumatoid Arthritis", "Sarcoidosis", "Systemic Sclerosis", "Scleroderma", "Sjogren's Syndrome", "Undifferentiated Connective Tissue Diseases" ], "interventions": [], "intervention_types": [], "sponsor": "Yale University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 5000, "start_date": "2020-08-04", "completion_date": "2030-06-01", "has_results": false, "last_update_posted_date": "2026-02-13", "last_synced_at": "2026-06-10T22:14:48.073Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT04402086" }, { "nct_id": "NCT05621369", "title": "Psorcast Mobile Study", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Psoriatic Arthritis", "Psoriasis", "Psoriatic Conditions", "Dermatologic Disease", "Rheumatologic Disease", "Psoriatic Nail", "Plaque Psoriasis", "Joint Pain", "Dactylitis" ], "interventions": [ { "name": "Participant self-assessment surveys", "type": "BEHAVIORAL" }, { "name": "Psoriasis Draw", "type": "BEHAVIORAL" }, { "name": "Psoriasis Area Photo", "type": "BEHAVIORAL" }, { "name": "Finger and Toe Photos", "type": "BEHAVIORAL" }, { "name": "Digital Jar Open", "type": "BEHAVIORAL" }, { "name": "30 Second Walk", "type": "BEHAVIORAL" }, { "name": "Psorcast mobile application", "type": "OTHER" } ], "intervention_types": [ "BEHAVIORAL", "OTHER" ], "sponsor": "Sage Bionetworks", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1000, "start_date": "2022-01-01", "completion_date": "2027-01-31", "has_results": false, "last_update_posted_date": "2026-06-01", "last_synced_at": "2026-06-10T22:14:48.073Z", "location_count": 1, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT05621369" }, { "nct_id": "NCT01307423", "title": "Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis (PsA)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Psoriatic Arthritis" ], "interventions": [ { "name": "Apremilast 20mg", "type": "DRUG" }, { "name": "Apremilast 30mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amgen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 529, "start_date": "2010-12-09", "completion_date": "2017-08-16", "has_results": true, "last_update_posted_date": "2022-06-14", "last_synced_at": "2026-06-10T22:14:48.073Z", "location_count": 30, "location_summary": "Phoenix, Arizona • Palm Desert, California • Doral, Florida + 26 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Palm Desert", "state": "California" }, { "city": "Doral", "state": "Florida" }, { "city": "Fort Lauderdale", "state": "Florida" }, { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01307423" }, { "nct_id": "NCT01365455", "title": "Efficacy and Safety of Subcutaneous Secukinumab for Moderate to Severe Chronic Plaque-type Psoriasis for up to 1 Year", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Moderate to Severe Plaque-type Psoriasis" ], "interventions": [ { "name": "secukinumab 150 mg", "type": "DRUG" }, { "name": "placebo to secukinumab 150 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 738, "start_date": "2011-06", "completion_date": "2013-04", "has_results": true, "last_update_posted_date": "2021-01-05", "last_synced_at": "2026-06-10T22:14:48.073Z", "location_count": 34, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Los Angeles, California + 26 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Oceanside", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01365455" }, { "nct_id": "NCT04751396", "title": "Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Ankylosing Spondylitis", "Autoimmune Disease", "Crohn Disease", "Enteropathic Arthritis", "Enteropathic Spondylitis", "Inflammatory Bowel Disease", "Melanoma", "Psoriasis", "Psoriatic Arthritis", "Reactive Arthritis", "Rheumatoid Arthritis", "Systemic Lupus Erythematosus", "Ulcerative Colitis" ], "interventions": [ { "name": "Best Practice", "type": "OTHER" }, { "name": "Educational Intervention", "type": "OTHER" }, { "name": "Interview", "type": "OTHER" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Survey Administration", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 125, "start_date": "2022-04-20", "completion_date": "2027-02-02", "has_results": false, "last_update_posted_date": "2026-05-20", "last_synced_at": "2026-06-10T22:14:48.073Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04751396" }, { "nct_id": "NCT07180537", "title": "Creating Health Course Study for People With Rheumatological Conditions", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Rheumatoid Arthritis", "Sjogren's Syndrome", "Systemic Lupus Erythematosus", "Mixed Connective Tissue Disease", "Psoriatic Arthritis" ], "interventions": [ { "name": "Creating Health Online Course", "type": "BEHAVIORAL" }, { "name": "Delayed access to Creating Health Online Course", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Terry L. Wahls", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "18 Years to 100 Years" }, "enrollment_count": 200, "start_date": "2025-12-01", "completion_date": "2027-12-31", "has_results": false, "last_update_posted_date": "2026-01-08", "last_synced_at": "2026-06-10T22:14:48.073Z", "location_count": 1, "location_summary": "Iowa City, Iowa", "locations": [ { "city": "Iowa City", "state": "Iowa" } ], "official_url": "https://clinicaltrials.gov/study/NCT07180537" } ] }